JP2008515980A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008515980A5 JP2008515980A5 JP2007536818A JP2007536818A JP2008515980A5 JP 2008515980 A5 JP2008515980 A5 JP 2008515980A5 JP 2007536818 A JP2007536818 A JP 2007536818A JP 2007536818 A JP2007536818 A JP 2007536818A JP 2008515980 A5 JP2008515980 A5 JP 2008515980A5
- Authority
- JP
- Japan
- Prior art keywords
- osamu
- prostaglandins
- prevention
- ester
- manufacture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 229940082622 Prostaglandin cardiac therapy preparations Drugs 0.000 claims 1
- 229940077717 Prostaglandin drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) Drugs 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000001404 mediated Effects 0.000 claims 1
- 229940094443 oxytocics Prostaglandins Drugs 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 150000003180 prostaglandins Chemical class 0.000 claims 1
Claims (2)
- プロスタグランジン媒介疾患又は病態の治療又は予防のための医薬組成物の製造における、請求項1に記載の化合物、又はそのエステルの使用。
- 薬学的に許容可能な担体と、請求項1に記載の化合物とを含む医薬製剤。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61820204P | 2004-10-12 | 2004-10-12 | |
PCT/US2005/036558 WO2006044405A1 (en) | 2004-10-12 | 2005-10-11 | Aryl sulfonamide peri-substituted bicyclics for occlusive artery disease |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2008515980A JP2008515980A (ja) | 2008-05-15 |
JP2008515980A5 true JP2008515980A5 (ja) | 2008-11-27 |
Family
ID=35677621
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007536818A Pending JP2008515980A (ja) | 2004-10-12 | 2005-10-11 | 閉塞性動脈疾患のためのアリールスルホンアミドぺリ置換二環式化合物 |
Country Status (17)
Country | Link |
---|---|
US (2) | US20060142348A1 (ja) |
EP (1) | EP1812426B1 (ja) |
JP (1) | JP2008515980A (ja) |
KR (1) | KR20070085340A (ja) |
CN (1) | CN101076529A (ja) |
AT (1) | ATE512144T1 (ja) |
AU (1) | AU2005295902A1 (ja) |
BR (1) | BRPI0517417A (ja) |
CA (1) | CA2583710A1 (ja) |
HK (1) | HK1110580A1 (ja) |
IL (1) | IL182489A0 (ja) |
MX (1) | MX2007004526A (ja) |
NO (1) | NO20072269L (ja) |
NZ (1) | NZ554493A (ja) |
RU (1) | RU2407736C2 (ja) |
SG (1) | SG156637A1 (ja) |
WO (1) | WO2006044405A1 (ja) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GT200500185A (es) * | 2004-08-09 | 2006-04-10 | Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos | |
DK1928454T3 (da) | 2005-05-10 | 2014-11-03 | Intermune Inc | Pyridonderivater til modulering af stress-aktiveret proteinkinasesystem |
US20090163586A1 (en) | 2007-12-20 | 2009-06-25 | Astrazeneca Ab | Bis-(Sulfonylamino) Derivatives in Therapy 205 |
ES2567283T3 (es) | 2008-06-03 | 2016-04-21 | Intermune, Inc. | Compuestos y métodos para tratar trastornos inflamatorios y fibróticos |
FR2938538B1 (fr) * | 2008-11-17 | 2011-08-05 | Univ Nice Sophia Antipolis | Procede de preparation d'acides et d'esters boroniques en presence de magnesium metallique |
AU2010232729A1 (en) | 2009-03-31 | 2011-10-20 | Arqule, Inc. | Substituted indolo-pyridinone compounds |
JP5841361B2 (ja) * | 2011-06-29 | 2016-01-13 | 壽製薬株式会社 | 三環性化合物及びそれを含有する医薬組成物 |
JO3407B1 (ar) | 2012-05-31 | 2019-10-20 | Eisai R&D Man Co Ltd | مركبات رباعي هيدرو بيرازولو بيريميدين |
AR092742A1 (es) | 2012-10-02 | 2015-04-29 | Intermune Inc | Piridinonas antifibroticas |
WO2015048553A1 (en) * | 2013-09-27 | 2015-04-02 | Allergan, Inc. | Compounds and methods for skin repair |
KR102373700B1 (ko) | 2014-04-02 | 2022-03-11 | 인터뮨, 인크. | 항섬유성 피리디논 |
GB201810581D0 (en) | 2018-06-28 | 2018-08-15 | Ctxt Pty Ltd | Compounds |
PE20220808A1 (es) | 2019-06-18 | 2022-05-20 | Pfizer | Derivados de benzisoxazol sulfonamida |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69609602T2 (de) * | 1995-04-03 | 2001-04-12 | Novartis Ag | Pyrazolderivate und verfahren zu deren herstellung |
ZA984040B (en) * | 1997-05-15 | 1998-11-20 | Ono Pharmaceutical Co | Benzenesulfonamide compounds |
ES2253266T3 (es) * | 1999-11-30 | 2006-06-01 | Pfizer Products Inc. | Compuestos de 2,4-diaminopirimidina utiles como inmunosupresores. |
EP1431267A4 (en) * | 2001-08-09 | 2004-12-22 | Ono Pharmaceutical Co | COMPOUNDS DERIVED FROM CARBOXYLIC ACID AND MEDICAMENTS COMPRISING SUCH COMPOUNDS AS ACTIVE INGREDIENT |
JPWO2004078719A1 (ja) * | 2003-03-06 | 2006-06-08 | 小野薬品工業株式会社 | インドール誘導体化合物およびその化合物を有効成分とする薬剤 |
WO2005005415A1 (en) * | 2003-07-09 | 2005-01-20 | Biolipox Ab | Indoles useful in the treatment of inflammation |
DK1696920T3 (en) * | 2003-12-19 | 2015-01-19 | Plexxikon Inc | RELATIONS AND PROCEDURES FOR THE DEVELOPMENT OF LAW MODULATORS |
-
2005
- 2005-10-11 US US11/247,456 patent/US20060142348A1/en not_active Abandoned
- 2005-10-11 AU AU2005295902A patent/AU2005295902A1/en not_active Abandoned
- 2005-10-11 SG SG200906805-7A patent/SG156637A1/en unknown
- 2005-10-11 EP EP05812269A patent/EP1812426B1/en active Active
- 2005-10-11 BR BRPI0517417-1A patent/BRPI0517417A/pt not_active IP Right Cessation
- 2005-10-11 CA CA002583710A patent/CA2583710A1/en not_active Abandoned
- 2005-10-11 RU RU2007115520/04A patent/RU2407736C2/ru not_active IP Right Cessation
- 2005-10-11 WO PCT/US2005/036558 patent/WO2006044405A1/en active Application Filing
- 2005-10-11 MX MX2007004526A patent/MX2007004526A/es unknown
- 2005-10-11 JP JP2007536818A patent/JP2008515980A/ja active Pending
- 2005-10-11 CN CNA200580042679XA patent/CN101076529A/zh active Pending
- 2005-10-11 KR KR1020077010839A patent/KR20070085340A/ko not_active Application Discontinuation
- 2005-10-11 NZ NZ554493A patent/NZ554493A/en not_active IP Right Cessation
- 2005-10-11 AT AT05812269T patent/ATE512144T1/de not_active IP Right Cessation
-
2007
- 2007-04-11 IL IL182489A patent/IL182489A0/en unknown
- 2007-05-02 NO NO20072269A patent/NO20072269L/no not_active Application Discontinuation
-
2008
- 2008-02-01 HK HK08101280.9A patent/HK1110580A1/xx not_active IP Right Cessation
- 2008-11-03 US US12/264,053 patent/US20090075985A1/en not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2008515980A5 (ja) | ||
JP2007501251A5 (ja) | ||
JP2007520565A5 (ja) | ||
JP2003520232A5 (ja) | ||
JP2008513510A5 (ja) | ||
JP2003503454A5 (ja) | ||
WO2007098128A3 (en) | Phenylephrine-containing liquid formulations | |
JP2007514005A5 (ja) | ||
JP2012502037A5 (ja) | ||
JP2006517944A5 (ja) | ||
CL2007001992A1 (es) | Compuestos derivados de pirimidilciclopentanos; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de una enfermedad inflamatoria, hiperproliferante, cardiovascular, neurodege | |
JP2010528011A5 (ja) | ||
JP2009538898A5 (ja) | ||
CL2007001993A1 (es) | Compuestos derivados de pirimidilciclopentanos hidroxilados y metoxilados; procedimiento de preparacion; composicion farmaceutica; y uso del compuesto en el tratamiento de una enfermedad inflamatoria, hiperproliferante, cardiovascular, neurodegenerat | |
HRP20220902T3 (hr) | Pripravci i njihova upotreba u liječenju multiple skleroze | |
JP2008505857A5 (ja) | ||
JP2007523135A5 (ja) | ||
WO2007093642A3 (fr) | Formes pharmaceutiques multimicroparticulaires qui resistent a la decharge immediate du principe actif en presence d'alcool | |
ITMI20011337A0 (it) | Composizioni farmaceutiche orali a rilascio modificato del principio attivo | |
JP2009537554A5 (ja) | ||
EA200901393A1 (ru) | Фармацевтическая композиция, содержащая гестагены и/или эстрогены и 5 метил-(6s)-тетрагидрофолат | |
JP2007238598A5 (ja) | ||
JP2005513006A5 (ja) | ||
DE602008006243D1 (de) | Pharmazeutische kombination aus aliskiren und valsartan | |
JP2003526626A5 (ja) |